09:50 AM EST - Theralase Technologies Inc. : announced today that it has publicly released two significant peer-reviewed research papers concerning the destruction of cancer. The first paper demonstrates the vaccine and immune "memory response" effects of Theralase's lead Photo Dynamic Compound (PDC), in the destruction of cancer in an animal model. The second paper demonstrates the effectiveness of Theralase's anti-cancer technology in destroying both normoxic (normally oxygenated) cancerous cells and hypoxic (low oxygenated) cancerous cells. Theralase Technologies Inc.
shares V.TLT are trading up $0.01 at $0.31.
